Scientific Industries Reports Second Quarter Fiscal 2026 Results
Rhea-AI Summary
Scientific Industries (OTCQB: SCND) reported net revenues of $1.47 million for the quarter and $2.70 million for the six months ended June 30, 2026, up 36.0% and 33.3% year over year, driven by higher volume across both segments. Gross profit rose to $622,700 and $1,092,600, with gross margins improving to 42.3% and 40.5%, helped by higher-margin DOTS bioprocessing products.
Operating expenses declined to $1,895,500 for the quarter and $4,033,200 year-to-date, down about 13% from the prior-year periods due to cost reductions and savings initiatives. Net loss narrowed to $1,233,800 (−$0.10 per share) for the quarter and $2,823,100 (−$0.24 per share) year-to-date, versus losses of $1,523,700 and $3,302,200 a year earlier. As of June 30, 2026, cash, cash equivalents and investments totaled $4,548,500 with working capital of $6,524,800.
Operationally, the company launched expanded VIVID subscription plans, plans to begin shipping its second-generation VIVID ONE in September 2026, is developing a VIVID WORKSTATION AI model targeted for Q1 2027, and continues DOTS platform and pH sensor development, including learnings from the first round of customer trials.
Positive
- Revenue growth +36.0% Q2 and +33.3% YTD vs prior-year periods
- Gross margin improved to 42.3% in Q2 and 40.5% YTD
- Operating expenses down ~13% for both Q2 and YTD 2026
- Net loss narrowed to $1.23M quarterly and $2.82M YTD
- Liquidity of $4.55M in cash, equivalents and investments at June 30, 2026
- Pipeline milestones: second-gen VIVID ONE shipping Sept 2026; AI workstation planned Q1 2027
Negative
- Company remains loss-making with $1.23M Q2 and $2.82M YTD net losses
- Q2 2025 benefited from $273,100 discontinued operations income not repeated in 2026
- Year-to-date 2025 had $552,700 discontinued operations income absent in 2026
AI-generated analysis. How Rhea-AI works. Not financial advice.
REVENUES UP
OPERATING EXPENSES DOWN
SUCCESSFUL LAUNCH OF EXPANDED VIVID SUBSCRIPTION PLANS
BOHEMIA, NY / ACCESS Newswire / August 14, 2026 / Scientific Industries, Inc. (OTCQB:SCND), a developer of digitally simplified bioprocessing solutions, vision-based pill counters and precision scales, today reported financial results for the three and six months ended June 30, 2026.
Business Highlights
Second-generation VIVID ONE will begin shipping in September 2026.
VIVID WORKSTATION AI model development is underway for a planned launch in the first quarter of 2027.
SBI began incorporating learnings from its first round of customer trials of the new pH sensor.
Work continues on the development of an AI tool to improve the customer experience with the DOTS Platform.
Three and Six Months Financial Results
Net revenues for the three and six months ended June 30, 2026 were
Gross profits were
Operating expenses were
The Company recast its financial results for the three and six months ended June 30, 2025 to reflect the discontinued operations related to the sale of the Genie Division of the Benchtop Laboratory Equipment Operations in August 2025. As a result, it reflected income of
The Company reported a net loss for the three and six months ended June 30, 2026 of
As of June 30, 2026, cash, cash equivalents and investments totaled
Management Commentary
Helena Santos, Chief Executive Officer of Scientific Industries, said, "At the mid-year point of our fiscal year we are highly encouraged by our results in both the VIVID and bioprocessing businesses, particularly with our new product development efforts. The revamped VIVID subscription plans are providing the Company with an important recurring revenue stream while providing customers with support options that fit their needs. Our machine learning VIVID model under development is showing extraordinary results and will position the VIVID as the premier automated pill counter in its class, and we are accomplishing all our goals while being mindful of the bottom line."
John Moore, Chairman, said "We are seeing exciting progress at Scientific Bioprocessing as we develop our DOTS sensing platform. Our pH sensor has yielded surprising insights beyond what we originally designed it to deliver, and we have completed the first round of customer trials. Bioprocessing today still relies heavily on manual, offline sampling, which leaves scientists working from a handful of data points across days of dynamic biology. A sensing approach that delivers continuous data - and extracts more meaning from that data - is what our customers need to shorten development timelines and improve the odds of successful scale-up."
About Scientific Industries, Inc.
Scientific Industries (OTCQB:SCND), designs, produces, and markets bioprocessing systems under the product name DOTS, and vision-based pill counters under the VIVID® brand in addition to weighing instruments under the brand Torbal®. Scientific Industries' products are generally used in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit www.scientificindustries.com and www.scientificbio.com.
Safe Harbor Statement
Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.
Company Contact:
Helena R. Santos
CEO and President
Phone: 631-567-4700
hsantos@scientificindustries.com
info@scientificindustries.com
FINANCIAL TABLES FOLLOW
SOURCE: Scientific Industries, Inc.
View the original press release on ACCESS Newswire